Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
unlimited free pdf from europmc33022015    free
PDF from PMC    free
html from PMC    free
PDF vom PMID33022015 :   free

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Biochemical screening for SARS-CoV-2 main protease inhibitors #MMPMID33022015
  • Coelho C; Gallo G; Campos CB; Hardy L; Wurtele M
  • PLoS One 2020[]; 15 (10): e0240079 PMID33022015show ga
  • The Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) pandemic represents a global challenge. SARS-CoV-2's ability to replicate in host cells relies on the action of its non-structural proteins, like its main protease (Mpro). This cysteine protease acts by processing the viruses' precursor polyproteins. As proteases, together with polymerases, are main targets of antiviral drug design, we here have performed biochemical high throughput screening (HTS) with recombinantly expressed SARS-CoV-2 Mpro. A fluorescent assay was used to identify inhibitors in a compound library containing known drugs, bioactive molecules and natural products. These screens led to the identification of 13 inhibitors with IC50 values ranging from 0.2 muM to 23 muM. The screens confirmed several known SARS-CoV Mpro inhibitors as inhibitors of SARS-CoV-2 Mpro, such as the organo-mercuric compounds thimerosal and phenylmercuric acetate. Benzophenone derivatives could also be identified among the most potent screening hits. Additionally, Evans blue, a sulfonic acid-containing dye, could be identified as an Mpro inhibitor. The obtained compounds could be of interest as lead compounds for the development of future SARS-CoV-2 drugs.
  • |Antiviral Agents/*pharmacology[MESH]
  • |Betacoronavirus/*drug effects/*enzymology[MESH]
  • |COVID-19[MESH]
  • |Coronavirus 3C Proteases[MESH]
  • |Coronavirus Infections/*virology[MESH]
  • |Cysteine Endopeptidases/chemistry[MESH]
  • |Drug Design[MESH]
  • |Drug Evaluation, Preclinical/*methods[MESH]
  • |Escherichia coli/genetics[MESH]
  • |Inhibitory Concentration 50[MESH]
  • |Models, Molecular[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*virology[MESH]
  • |Protease Inhibitors/*pharmacology[MESH]
  • |SARS-CoV-2[MESH]
  • |Viral Nonstructural Proteins/*antagonists & inhibitors/chemistry[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    e0240079 10.15 2020